Fibromyalgia syndrome – Novel therapeutic agents. J. Ablin and D. Buskila. Maturitas 2013 “The long term follow-up of FMS patients indicates…..that the degree of improvement achieved by many medications…is modest at best”  Ablin and Buskia Affecting 2-3% of the population of the US or about 8,000,000 people in the US … Continue reading The Fibromyalgia Drugs Your Doctor (Probably) Knows Nothing About